Your contact

Gabriele Klingner

Communications & Marketing Lead

Christiane Proll

PR & Social Media Manager

Newsletter

Newsletter
The free BioM newsletter contains news from the biotech industry in Munich and Bavaria, as well as information on events and funding programs for the life sciences. The BioM newsletter is published every two weeks. You can unsubscribe at any time.

Post press release

Post press release

HERA plans two EU4Health tenders for May 2026: Next-generation therapeutics for infectious diseases and Filovirus investigational vaccine reserve (Marburg/Sudan Ebola)

Under EU4Health, the European Health Emergency Preparedness and Response Authority HERA is expected to publish two calls for tenders in May 2026:

  • Next Generation Therapeutics for Infectious Diseases (PCP): Multiple sourcing Framework Contracts to speed up the development of and access to innovative medical countermeasures Next Generation Therapeutics for Infectious Diseases. Estimated publication: 27 May 2026.
    Funding & Tenders Portal:  HADEA/2026/OP/0015-PIN
  • Clinical Trial Readiness through the Establishment of a Pilot Filovirus Investigational Vaccine Reserve:
    Establish, pilot and maintain an EU-based reserve of investigational vaccine candidates against Marburg (MARV) and/or Sudan Ebola (SUDV), enabling rapid integration into outbreak-associated clinical trials.
    Estimated publication: 18 May 2026.
    Funding & Tenders Portal: HADEA/2026/OP/0019-PIN

For questions and support, please contact the National Contact Point EU4Health.